Advisor Group’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Advisor Group’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-750	Closed	-$27K	–	4934
2016 Q4	$27K	Hold	750	–	–	﹤0.01%	3054
2016 Q3	$29K	Hold	750	–	–	﹤0.01%	2916
2016 Q2	$6K	Buy	+750	New	+$5.04K	﹤0.01%	3741

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Advisor Group's CLCD Position: Q1 2017 in Review

Advisor Group sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 750 shares — an estimated $27K sold.

Advisor Group first reported a position in CLCD in Q2 2016 and held it in 3 quarters. The position peaked at $29K in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Advisor Group reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Advisor Group sold 750 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $27K.
Advisor Group first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2016 and held it in 3 quarters.
Advisor Group's CoLucid Pharmaceuticals, Inc. position peaked at $29K in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Advisor Group's 13F filing for Q1 2017, filed 15 May 2017.